Response to Letter to the Editor Regarding: 2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors
- PMID: 32732648
- DOI: 10.1097/LGT.0000000000000562
Response to Letter to the Editor Regarding: 2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors
Comment on
-
2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors.J Low Genit Tract Dis. 2020 Apr;24(2):102-131. doi: 10.1097/LGT.0000000000000525. J Low Genit Tract Dis. 2020. PMID: 32243307 Free PMC article. No abstract available.
-
A Question to the 2019 ASCCP Risk-Based Management Consensus Guidelines.J Low Genit Tract Dis. 2020 Oct;24(4):425. doi: 10.1097/LGT.0000000000000561. J Low Genit Tract Dis. 2020. PMID: 32796263 No abstract available.
References
REFERENCE
-
- Perkins RB, Guido RS, Castle PE, et al.; 2019 ASCCP Risk-Based Management Consensus Guidelines Committee. 2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors. J Low Genit Tract Dis 2020;24:102–31.
